Selexipag vs placebo
Improvement in WHO functional class · pulmonary arterial hypertension
Selexipag showed no clear difference in improvement in WHO functional class compared with placebo (moderate certainty).
1 finding from 1 review
- OR 1.61 [0.17, 15.63]1 study · 43 participantsModerate